Companies Dominating the Wearable Cardioverter Defibrillators Landscape
- ZOLL Medical Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Element Science Inc.
- Medtronic plc
- Kestra Medical Technologies, Inc.
- Abbott
- Boston Scientific Corporation
- LivaNova plc
- Koninklijke Philips N.V.
- Nihon Kohden Corporation
- General Electric Company.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of wearable cardioverter defibrillators is evaluated at USD 274.58 million.
The wearable cardioverter defibrillators market size was valued at USD 254.06 million in 2024 and is expected to reach USD 826.65 million by 2037, expanding at around 9.5% CAGR during the forecast period i.e., between 2025-2037. Rising incidence of heart attacks across the globe and growing technological advancement in cardiology will drive the market growth.
North America industry is expected to hold largest revenue share of 38% by 2037, impelled by rising funding in the healthcare industry in the region.
The major players in the market are ZOLL Medical Corporation, Element Science Inc., Medtronic plc, Kestra Medical Technologies, Inc., Abbott, Boston Scientific Corporation, LivaNova plc, Koninklijke Philips N.V., Nihon Kohden Corporation and General Electric Company., and others.
The market in the North American region is projected to hold the largest market share by the end of 2037 and provide more business opportunities in the future.
